DNA alkylation and repair in the large bowel: Animal and human studies

Journal of Nutrition

Volumn 132, Issue 11 SUPPL., 2002, Pages

  Povey, Andrew C ^a   Badawi, Alaa F ^b   Cooper, Donald P ^b   Nicholas Hall, C ^c   Harrison, Kathryn L ^a   Jackson, Peta E ^b   Lees, Nicholas P ^c   O'Connor, Peter J ^b   Margison, Geoffrey P ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Colorectal cancer; K ras; MGMT; O6 alkylguanine DNA alkyltransferase; O6 methylguanine

Indexed keywords

6 O ALKYLGUANINE DNA ALKYLTRANSFERASE; 6 O METHYLGUANINE; ADENINE; CYTOSINE; GUANINE; THYMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CANCER RISK; COLON ADENOMA; COLON TUMOR; COLORECTAL CANCER; CONFERENCE PAPER; DNA ADDUCT; DNA ALKYLATION; DNA METHYLATION; DNA REPAIR; FEMALE; GENE MUTATION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; LARGE INTESTINE; MOUSE; MUTAGENICITY; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; ONCOGENE K RAS; PROMOTER REGION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0036847355     PISSN: 00223166     EISSN: None     Source Type: Journal    
DOI: 10.1093/jn/132.11.3518s     Document Type: Conference Paper

References (63)

1. de la Chapelle, A. & Peltomaki, P. (1995) Genetics of hereditary colon cancer. Annu. Rev. Genet 29: 329-348.
2. Feamhead, N. S., Britton, M. P. & Bodmer, W. F (2001) The ABC of APC. Hum. Mol. Genet. 10: 721-723.
3. Potter, J. D., Slattery, M. L., Bostick, R. M. & Gapstur, S. M. (1993) Colon cancer: A review of the epidemiology. Epidemiol. Rev. 15: 499-545.
4. Cho, K. R. & Vogelstein, B. (1992) Genetic alterations in the adenoma-carcinoma sequence. Cancer 70: 1727-1731.
5. Bos, J. L. (1989) Ras oncogenes in human cancer: A review. Cancer Res. 49: 4682-4689.
6. Alexandrov, K., Rojas, M., Kadlubar, F. F., Lang, N. P. & Bartsch, H. (1996) Evidence of anti-benzo[a]pyrene diolepoxide-DNA adduct formation in human colon mucosa. Carcinogenesis 17: 2081-2083.
7. Totsuka, Y., Fukutome, K., Takahashi, M., Takahashi, S., Tada, A., Sugimura, T. & Wakabayashi, K. (1996) Presence of N2-(deoxyguanosin-8-yl)-2-amino-3,8-dimethylimidazo [4,5-f] quinoxaline (dG-C8-MelQx) in human tissues. Carcinogenesis 17: 1029-1034.
8. Pfohl-Leszkowicz, A., Grosse, Y., Carriere, V., Cugnenc, P.-H., Berger, A., Carnot, F., Beaune, P. & de Waziers, I. (1995) High levels of DNA adducts in human colon are associated with colorectal cancer. Cancer Res. 55: 5611-5616.
9. Hall, C. N., Badawi, A. F., O'Connor, P. J. & Saffhill, R. (1991) The detection of alkylation damage in the DNA of human gastrointestinal tissues. Br. J. Cancer 64: 59-63.
10. Harrison, K. L., Wood, M., Lees, N. P., Hall, C. N., Margison, G. P. & Povey, A. C. (2001) Development and application of a sensitive and rapid immunoassay for the quantitation of N7-methyldeoxyguanosine in DNA samples. Chem. Res. Toxicol. 14: 295-301.
11. 6-methylguanine, in normal DNA from the cancer prone regions of the large bowel. Gut 47: 362-365.
12. Bartsch, H. & Montesano, R. (1984) Relevance of nitrosamines to human cancer. Carcinogenesis 5: 1381-1393.
13. Hotchkiss, J. H. (1987) A review of current literature on N-nitroso compounds in foods. Adv. Food Res 31: 53-115.
14. Kyrtopoulos, S. A. (1998) DNA adducts in humans after exposure to methylating agents. Mutat. Res, 405: 135-143.
15. Wilson, V. L., Weston, A., Manchester, D. K., Trivers, G. E., Roberts, D. W., Kadlubar, F. F., Wild, C. P., Montesano, R. Willey, J. C., Mann, D. L. & Harris, C. C. (1989) Alkyl and aryl carcinogen adducts detected in human peripheral lung. Carcinogenesis 10: 2149-2152.
16. 6-methylguanine in DNA. Cancer Res. 57: 366-369.
17. 6-Alkylguanine-DNA alkyltransferase: Role in carcinogenesis and chemotherapy. Bioessays 24: 255-266.
18. 6-methylguanine residues in genomic DNA and production of sister chromatid exchanges, mutations and lethal events in a Mer- human tumor cell line. Mutat. Res. 314: 99-113.
19. Connor, P. J., Manning, F. C., Gordon, A. T., Billett, M. A., Cooper, D. P., Elder, R. H. & Margison, G. P. (2000) DNA repair: Kinetics and thresholds. Toxicol. Pathol. 28: 375-381.
20. Hong, M. Y., Chapkin, R. S., Wild, C. P., Morris, J. S., Wang, N., Carroll, R. J., Turner, N. D. & Lupton, J. R. (1999) Relationship between DNA adduct levels, repair enzyme and apoptosis as a function of DNA methylation by azoxymethane. Cell Growth Differ. 10: 749-758.
21. 6-alkylguanine by alkyltransferases. Mutat. Res. 462: 83-100.
22. 6-benzylguanine or 1,3-bis(2-chloroethyl)-1-nitrosourea. Biochemistry 35: 1328-1334.
23. Kaina, B., Fritz, G., Ochs, K., Haas, S., Grombacher, T., Dosch, J., Christmann, M., Lund, P., Gregel, C. M. & Becker, K. (1998) Transgenic systems in studies on genotoxicity of alkylating agents: Critical lesions, thresholds and defense mechanisms. Mutat. Res. 405: 179-191.
24. 6-methylguanine DNA adducts on the adenosine nucleotide switch functions of hMSH2-hMSH6 and hMSH2-hMSH3. J. Biol. Chem. 275: 27851-27857.
25. Boley, S. E., McManus, T. P., Maher, V. M. & McCormick, J.J. (2000) Malignant transformation of human fibroblast cell strain MSU-1.1 by N-methyl-N-nitrosourea: Evidence of elimination of p53 by homologous recombination. Cancer Res. 60: 4105-4111.
26. Kawate, H., Itoh, R., Sakumi, K., Nakabeppu, Y., Tsuzuki, T., Ide, F., Ishikawa, T., Noda, T., Nawata, H. & Sekiguchi, M. (2000) A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice. Carcinogenesis 21: 301-305.
27. 6-alkylguanine-DNA alkyltransferase activity in normal and tumour tissue from human colon and rectum. Int. J. Cancer 85: 68-72.
28. 6-Alkylguanine-DNA alkyltransferase in normal colon tissue and colon cancer. Oncol. Res. 9: 149-153.
29. 6-alkylguanine-DNA alkyltransferase activity in human colon cancer. Clin. Cancer Res. 1: 519-525.
30. 6-alkylguanine DNA-alkyltransferase activity in the human colon and rectum. Br. J. Cancer (in press).
31. Weisburger, J. H. & Fiala, E. S. (1983) Experimental colon carcinogens and their mode of action. In: Experimental Colon Carcinogenesis (Autrup, H. & Williams, G. M., eds.), pp. 27-50. CRC Press, Boca Raton, FL,
32. Jacoby, R. F., Hohman, C., Marshall, D. J., Frick, T. J., Schlack, S., Broda, M., Smutko, J. & Elliott, R. W. (1994) Genetic analysis of colon cancer susceptibility in mice. Genomics 22: 381-387.
33. Moen, C. J. A., Groot, P. C., Hart, A. A. M., Snoek, M. & Demant, P. (1996) Fine mapping of colon tumor susceptibility (Scc) genes in the mouse, different from the genes known to be somatically mutated in colon cancer. Proc. Natl. Acad. Sci. U.S.A. 93: 1082-1086.
34. Van Wezel, T., Stassen, A. P. M., Moen, C. J. A., Hart, A. A. M., Van der Valk, M. A. & Demant, P. (1996) Gene interaction and single gene effects in colon tumour susceptibility in mice. Nat. Genet. 14: 468-470.
35. Van Wezel, T., Ruivenkamp, C. A., Stassen, A. P., Moen, C. J. & Demant, P. (1999) Four new colon cancer susceptibility loci, Scc6 to Scc9 in the mouse. Cancer Res. 59: 4216-4218.
36. Kim, J. M., Araki, S., Kim, D. J., Park, C. B., Takasuka, N., Baba-Toriyama, H., Ota, T., Nir, Z., Khachik, F., Shimidzu, N., Tanaka, Y., Osawa, T., Uraji, T., Murakoshi, M., Nishino, H. & Tsuda, H. (1998) Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation. Carcinogenesis 19: 81-85.
37. Park, H. S., Goodlad, R. A. & Wright, N. A. (1997) The incidence of aberrant crypt foci and colonic carcinoma in dimethylhydrazine-treated rats varies in a site-specific manner and depends on tumor histology. Cancer Res. 57: 4507-4510.
38. Carter, J. W. Lancaster, H. K., Hardman, W. E. & Cameron, I. L. (1994) Distribution of intestine-associated lymphoid tissue, aberrant crypt foci and tumors in the large bowel of 1,2-dimethylhydrazine-treated mice. Cancer Res. 54: 4304-4307.
39. Chang, W. W. L. (1984) Histogenesis of colon cancer in experimental animals. Scand. J. Gastroenterol. 19: 27-43.
40. Evans, J. T., Hauschka, T. S. & Mittelman, A. (1974) Differential susceptibility of four mouse strains to induction of multiple large-bowel neoplasms by 1,2-dimethylhydrazine. J. Natl. Cancer Inst. 52: 999-1000.
41. Turusov, V. S., Lanko, N. S., Krutovskikh, V. A. & Parfenov, Y. D. (1982) Strain differences in susceptibility of female mice to 1,2-dimethylhydrazine. Carcinogenesis 3: 603-608.
42. Diwan, B. A., Meier, H. & Blackman, K. E. (1977) Genetic differences in the induction of colorectal tumors by 1,2-dimethylhydrazine in inbred mice. J. Natl. Cancer Inst. 59: 455-458.
43. Bolognesi, C., Mariani, M. R. & Boffa, L. C. (1988) Target tissue DNA damage in inbred mouse strains with different susceptibility to the colon carcinogen 1,2-dimethylhydrazine. Carcinogenesis 9: 1347-1350.
44. Cooper, H. K., Buecheler, J. & Kleihues, P. (1978) DNA alkylation in mice with genetically different susceptibility to 1,2-dimethylhydrazine-induced colon carcinogenesis. Cancer Res. 38: 3063-3065.
45. James, J. T. & Autrup, H. (1983) Methylated DNA adducts in the large intestine of ICR/Ha and C57BL/Ha mice given 1,2-dimethylhydrazine. J. Natl. Cancer Inst. 70: 541-546.
46. Papanikolaou, A., Shank, R. C., Delker, D. A., Povey, A. Cooper, D. P. & Rosenberg, D. W. (1998) Initial levels of azoxymethane-induced DNA methyl adducts are not predictive of tumor susceptibility in inbred mice. Toxicol. Appl. Pharmacol. 150: 196-203.
47. 6-methylguanine and 7-methylguanine formation and persistence in DNA of rats treated with symmetrical dimethylhydrazine. Cancer Res. 41: 3967-3972.
48. Herron, D. C. & Shank, R. C. (1982) DNA methylation during chronic administration of 1,2-dimethylhydrazine in a carcinogenic regimen. Carcinogenesis 3: 857-860.
49. Swenberg, J. A., Cooper, H. K., Bucheler, J. & Kleihues, P. (1979) 1,2-Dimethylhydrazine-induced methylation of DNA bases in various rat organs and the effect of pretreatment with disulfiram. Cancer Res. 39: 465-467.
50. Potten, C. S., Li, Y. Q., O'Connor, P. J. & Winton, D. J. (1992) A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel. Carcinogenesis 13: 2305-2312.
51. 6-alkylguanine-DNA alkyltransferase and cellular proliferation in the rat colon. Carcinogenesis 14: 1175-1179.
52. McGarrity, T. J., Pfeiffer, L. P. & Colony, P. C. (1988) Cellular proliferation in proximal and distal rat colon during 1,2-dimethylhydrazine-induced carcinogenesis. Gastroenterology 95: 343-348.
53. Jackson, P. E., Cooper, D. P., O'Connor, P. J. & Povey, A. C. (1999) The relationship between 1,2-dimethylhydrazine dose and the induction of colon tumours: Tumour development in female SWR mice does not require a K-ras mutational event. Carcinogenesis 20: 509-513.
54. 6-alkylguanine-DNA alkyltransferase inactivation assay. Toxicol. Lett. 115: 205-212.
55. Jacoby, R. F., Llor, X., Teng, B.-B., Davidson, N. O. & Brasitus, T. A. (1991) Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplasic and neoplastic rat colonic mucosa. J. Clin. Invest. 87: 624-630.
56. Zaidi, N. H., Pretlow, A. P., O'Riordan, M. A., Dumenco, L. L., Allay, E. & Gerson, S. L. (1995) Transgenic expression of human MGMT protects against azoxymethane-induced aberrant crypt foci and G to A mutations in the K-ras oncogene of mouse colon. Carcinogenesis 16: 451-456.
57. Jackson, P. E., Hall, C. N., Badawi, A. F., O'Connor, P. J., Cooper, D. P. & Povey, A. C. (1996) The frequency of K-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester. Mol. Carcinog. 16: 12-19.
58. 6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC-AT transition in the K-ras oncogene. Carcinogenesis 18: 1299-1302.
59. Herfarth, K. K., Brent, T. P., Danam, R. P., Remack, J. S., Kodner, I. J., Wells, S. A., Jr. & Goodfellow, P. J. (1999) A specific CpG methylation pattern of the MGMT promoter region associated with reduced MGMT expression in primary colorectal cancers. Mol. Carcinog. 24: 90-98.
60. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res. 60: 2368-2371.
61. 6-methylguanine DNA methyltransferase characterizes a subset of colorectal cancer with low-level DNA microsatellite instability. Cancer Res. 61:827-830.
62. 6-alkylguanine DNA alkyltransferase (MGMT) activity in normal colorectal tissue and adenomas is associated with K-ras GC-AT gene mutations. Proc. Am. Assoc. Cancer Res. 5049: 1020.
63. 6-methylguanine and the cytotoxicity of methylating agents. Mutat. Res. 462: 71-82.